Spadin analog that blocks TREK-1 potassium channels for rapid antidepressant effects. PE-22-28 works through a novel mechanism distinct from traditional antidepressants, showing rapid onset of action in research studies.
Neural Network
Nootropic peptides enhance synaptic plasticity and neurotransmitter release.
Quickstart Highlights
- Dosage: 50-100mcg
- Frequency: Daily
- Administration: Intranasal or subcutaneous
- Cycle length: 4-8 weeks
Dosing Plan
| Weeks | Dose | Units |
|---|---|---|
| Starting | 50mcg once daily | Assess response |
| Standard | 100mcg once daily | Morning administration |
How This Works
PE-22-28 is derived from Spadin and blocks TREK-1 (TWIK-related potassium channel 1). TREK-1 channels are involved in depression, and their blockade leads to increased serotonin and neurogenesis in the hippocampus. This mechanism is distinct from SSRIs and may provide faster onset of antidepressant effects.
Mechanism of Action
How PE-22-28 Works in Your Body
Peptide Administered
Crosses the blood-brain barrier
Neurotransmitter Boost
Enhances BDNF and neurotrophic factors
Synaptic Activity
Neurons fire more efficiently, forming new connections
Focus & Memory
Improved clarity, recall, and cognitive performance
Benefits & Side Effects
Potential Benefits
- Rapid-acting antidepressant mechanism
- Promotes hippocampal neurogenesis
- Novel target distinct from traditional antidepressants
- May work when SSRIs have failed
Potential Side Effects
- Limited human safety data
- Experimental compound
- Potential for mild stimulation
Good to know
- Works through TREK-1 channel blockade - novel mechanism.
- May show effects faster than traditional antidepressants.
- Research compound - limited human data.
- Promotes neurogenesis in the hippocampus.
- Use in morning to avoid potential sleep disruption.
Community Insights
Summarised from 3 sourcesSpadin analog that blocks TREK-1 potassium channels for rapid antidepressant effects. PE-22-28 works through a novel mechanism distinct from traditional antidepressants, showing rapid onset of action in research studies. Fast-acting antidepressant mechanism. Novel approach to depression
Common Dosages Reported
- 50-100mcg Daily
- Standard protocol dosing
Side Effects Mentioned
- Generally mild, individual variation expected
- See full guide for detailed safety info
Stacking Suggestions
- Consult research and healthcare provider before stacking
What people are saying
Results vary based on individual response
Consistent dosing and timing important
Reviews & Discussion
Real experiences shared by the community — not medical advice.
PE 22-28 Duration vs Spadin
In a discussion regarding TREK-1 inhibitors, a user highlighted that PE 22-28 serves as a shortened analog of spadin with a significantly improved duration of action. The peptide reportedly maintains its effects for up to 23 hours, a substantial increase over the 7-hour duration associated with the original spadin molecule.
Rapid-acting antidepressant potential
A user noted that PE-22-28 shows significant promise for the treatment of mood disorders such as depression and anxiety. They emphasized its rapid-acting effects and a more favorable side-effect profile compared to traditional treatments.
Mood Enhancement Recognition
A user identified PE-22-28 as a mood-enhancing peptide. They noted that it is a fragment of Spadin with the amino acid sequence GVSWGLR.
Potential for Mood Disorder Treatment
A user highlighted the peptide's potential for addressing mood disorders, specifically depression and anxiety. They noted its reputation for rapid-acting effects and a more favorable side-effect profile compared to traditional treatments.
Pharmacological comparison of PE-22-28 and Spadin
A discussion of the peptide's pharmacological profile notes that PE-22-28 acts as a TREK-1 inhibitor with a significantly longer duration of action than its predecessor, Spadin. Research indicates its effects can last up to 23 hours, compared to only 7 hours for Spadin.
PE-22-28 as a Mood Enhancer
A user identified PE-22-28 as a mood-enhancing peptide. They noted that it is a fragment of Spadin with the amino acid sequence GVSWGLR.
No discussion yet — be the first.
No notes yet — be the first.